| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |